Best Peptides for Muscle Growth — Evidence Review
Muscle hypertrophy in healthy adults is dominated by mechanical loading (resistance training), adequate protein intake, and time. Peptide therapy plays at most an adjunctive role, and most options…
Muscle hypertrophy in healthy adults is dominated by mechanical loading (resistance training), adequate protein intake, and time. Peptide therapy plays at most an adjunctive role, and most options carry meaningful safety considerations or competitive-sport prohibition.
This guide is honest about the case for each compound and the reasons clinical recommendation is narrow.
Peptides with the most muscle-relevant data
IGF-1 LR3
Insulin-like growth factor 1 with extended pharmacokinetics. Direct muscle-anabolic action via IGF-1 receptor signaling. Animal models and small human studies report meaningful effects on muscle mass and strength.
Cancer-relevant safety considerations are substantial. IGF-1 elevation correlates with several cancer-incidence patterns in epidemiologic data; sustained supraphysiologic IGF-1 is the central concern. WADA prohibited substance (Class S2).
MK-677 (Ibutamoren)
Orally active GH secretagogue. Increases GH and IGF-1 sustainably. Has been studied in older-adult populations for sarcopenia and body composition. Side effects include water retention, increased appetite, and modest insulin-resistance changes.
WADA prohibited substance.
CJC-1295 + Ipamorelin
GH-secretagogue stack — GHRH analog plus selective ghrelin receptor agonist. Pulsatile GH elevation rather than sustained. Theoretical advantage of preserving physiologic pulsatility. Body-composition data in healthy adults is limited; most evidence is in age-related GH decline contexts.
WADA prohibited.
Full CJC-1295 profile → | Full ipamorelin profile →
MGF (Mechano Growth Factor)
IGF-1 splice variant produced in muscle response to mechanical loading. Animal-model evidence in muscle injury repair and hypertrophy. Human therapeutic data is limited.
Supporting cast
Hexarelin
Earlier-generation GH secretagogue. Less selective than ipamorelin — elevates cortisol and prolactin. Mostly superseded by ipamorelin for muscle-focused use cases.
BPC-157
Animal-model tissue-repair evidence. Not a muscle-anabolic peptide directly. Relevance is in injury-recovery contexts where tissue repair affects training continuity.
Important: WADA / NCAA / professional sports
Every GH secretagogue and IGF-1-family peptide on this page is on the WADA prohibited list. Athletes subject to drug testing should treat these compounds as testable, including in-competition and out-of-competition windows. National anti-doping organizations may have additional restrictions and longer detection-window protocols.
What the evidence does not support
- GLP-1 agonists for muscle growth — they cause lean-mass loss
- Tissue-repair peptides (BPC-157, TB-500) as primary muscle-building agents
- "Anabolic peptide stacks" without controlled-trial efficacy or safety data
- Use as substitute for resistance training and adequate protein intake
Practical considerations
For healthy adults pursuing muscle growth:
- Resistance training (progressive overload) is the strongest single intervention
- Adequate protein (1.6–2.2 g/kg lean mass per day)
- Sleep adequacy (7–9 hours; affects GH pulsatility naturally)
- Caloric balance appropriate to goal
Peptide therapy is at best adjunctive and carries IGF-1-related and competitive-sport risks. The clinical case for healthy-adult use is narrow.
Where to source
- IGF-1 LR3 vendor rankings — limited; sourcing requires research-use vendor selection
- MK-677 vendor rankings — orally active, broader vendor pool
- Ipamorelin vendor rankings — 19 ranked vendors
- CJC-1295 vendor rankings — data aggregating
What we don't know
- Long-term cancer-incidence data in users of sustained-IGF-1-elevation peptides
- Optimal training-protocol pairing for peptide-supported hypertrophy
- Whether MK-677's metabolic side effects (water retention, insulin resistance) matter long-term
- Comparative effectiveness against testosterone replacement therapy in age-related muscle loss
Methodology
Read the full methodology.
This page is educational. Athletes should consult anti-doping rules. Healthy adults considering muscle-growth peptides should weigh IGF-1-related cancer concerns against marginal hypertrophy benefit beyond what training and nutrition produce.